Paxlovid in patients who are immunocompromised and hospitalised with SARS-CoV-2 infection

F Sun, Y Lin, X Wang, Y Gao, S Ye - The Lancet infectious diseases, 2022 - thelancet.com
The omicron variant of SARS-CoV-2 has been reported in Shanghai, China, since March
2022. In two months, the emergence of the omicron variant has resulted in 600 000 …
被引用次数：60 相关文章

Paxlovid in patients who are immunocompromised and hospitalised with SARS-CoV-2 infection.

F Sun, Y Lin, X Wang, Y Gao, S Ye - The Lancet. Infectious …, 2022 - europepmc.org
The omicron variant of SARS-CoV-2 has been reported in Shanghai, China, since March
2022. In two months, the emergence of the omicron variant has resulted in 600 000 …

[引用][C] Paxlovid in patients who are immunocompromised and hospitalised with SARS-CoV-2 infection

F Sun, Y Lin, X Wang, Y Gao… - The Lancet. Infectious …, 2022 - pubmed.ncbi.nlm.nih.gov
Paxlovid in patients who are immunocompromised and hospitalised with SARS-CoV-2
infection Paxlovid in patients who are immunocompromised and hospitalised with SARS-CoV-2 …
[HTML] nih.gov

[HTML][HTML] Paxlovid in patients who are immunocompromised and hospitalised with SARS-CoV-2 infection

F Sun, Y Lin, X Wang, Y Gao, S Ye - The Lancet. Infectious …, 2022 - ncbi.nlm.nih.gov
The omicron variant of SARS-CoV-2 has been reported in Shanghai, China, since March
2022. In two months, the emergence of the omicron variant has resulted in 600 000 …

[引用][C] Paxlovid in patients who are immunocompromised and hospitalised with SARS-CoV-2 infection

F Sun, Y Lin, X Wang, Y Gao… - The Lancet. Infectious …, 2022 - pubmed.ncbi.nlm.nih.gov
Paxlovid in patients who are immunocompromised and hospitalised with SARS-CoV-2
infection Paxlovid in patients who are immunocompromised and hospitalised with SARS-CoV-2 …